Comparison of ampicillin and nalidixic acid in the treatment of urinary tract infections caused by E. coli.
作者信息
Toivonen S, Pentikäinen P, Leirisalo M, Pyörälä K
出版信息
Acta Med Scand. 1974 Mar;195(3):181-4. doi: 10.1111/j.0954-6820.1974.tb08120.x.
Abstract
摘要
相似文献
1
Comparison of ampicillin and nalidixic acid in the treatment of urinary tract infections caused by E. coli.
Acta Med Scand. 1974 Mar;195(3):181-4. doi: 10.1111/j.0954-6820.1974.tb08120.x.
2
Nalidixic acid by intravenous infusion. A report of 50 cases.
Br J Urol. 1972 Aug;44(4):503-9. doi: 10.1111/j.1464-410x.1972.tb10114.x.
3
Extended therapy in patients with established urinary tract infection.
Scott Med J. 1971 Mar;16(3):169-72. doi: 10.1177/003693307101600301.
4
Effect of a three-day course of nalidixic acid in the frequency-dysuria syndrome with significant bacteriuria in women.
Scand J Infect Dis. 1983;15(1):71-4. doi: 10.3109/inf.1983.15.issue-1.11.
5
The role of introital enterobacteria in recurrent urinary infections.
Trans Am Assoc Genitourin Surg. 1972;64:108-13.
6
Nalidixic acid in urinary tract infections with particular reference to the emergence of resistance.
Scand J Infect Dis. 1974;6(3):259-64. doi: 10.3109/inf.1974.6.issue-3.09.
7
A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
J Urol. 1981 Jun;125(6):822-4. doi: 10.1016/s0022-5347(17)55219-2.
8
[Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections].
Hinyokika Kiyo. 1965 Sep;11(9):913-34.
9
Practical guidelines in treating urinary tract infections.
Int J Clin Pharmacol. 1972 Aug;6(3):269-75.
10
[Clinical use of Wintomylon (nalidixic acid) in the field of urology].
Hinyokika Kiyo. 1965 Oct;11(10):1011-4.
引用本文的文献
1
Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.
Antimicrob Agents Chemother. 1981 Apr;19(4):598-604. doi: 10.1128/AAC.19.4.598.
Zotero 插件